Consolidated Balance Sheets - USD ($) shares in Thousands, $ in Millions	Sep. 30, 2021	Sep. 30, 2020
Current Assets
Cash and equivalents	$ 2,354	$ 3,315
Receivables, less allowances of $116 in 2021 and $138 in 2020	2,971	2,802
Inventories	2,050	1,928
Other current assets	1,057	761
Total current assets	8,432	8,806
Property, plant and equipment, net	3,738	3,688
Other assets
Goodwill	7,723	6,734
Other intangible assets	2,877	2,468
Other	1,945	1,186
Total other assets	12,545	10,388
Total assets	24,715	22,882
LIABILITIES AND EQUITY
Short-term borrowings and current maturities of long-term debt	872	1,160
Accounts payable	2,108	1,715
Accrued expenses	3,266	2,910
Total current liabilities	6,246	5,785
Long-term debt	5,793	6,326
Other liabilities	2,753	2,324
Equity
Common stock, $0.50 par value per share; authorized, 1,200.0 shares; issued, 953.4 shares; outstanding, 595.8 shares in 2021 and 598.0 shares in 2020	477	477
Additional paid-in-capital	522	470
Retained earnings	26,047	24,955
Accumulated other comprehensive income (loss)	(872)	(1,577)
Common stockholders' equity before treasury stock	26,174	24,325
Less: Cost of common stock in treasury, 357.6 shares in 2021 and 355.4 shares in 2020	16,291	15,920
Common stockholders’ equity	9,883	8,405
Noncontrolling interests in subsidiaries	40	42
Total equity	9,923	8,447
Total liabilities and equity	$ 24,715	$ 22,882
Common stock, par value per share	$ 0.50	$ 0.50
Common stock, shares authorized	1,200,000	1,200,000
Common stock, shares issued	953,400	953,400